These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Diagnosis and treatment of gout. Meltzler M BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24493155 [No Abstract] [Full Text] [Related]
6. [Gout and other crystal-induced arthritides]. Manger B Dtsch Med Wochenschr; 2012 Aug; 137(31-32):1579-81. PubMed ID: 22786675 [No Abstract] [Full Text] [Related]
7. New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond. Schlesinger N Curr Rheumatol Rep; 2010 Apr; 12(2):130-4. PubMed ID: 20425022 [TBL] [Abstract][Full Text] [Related]
8. Alternative treatment for chronic gout could relieve pain for thousands. The recently approved intravenous drug, pegloticase, may work when other treatments don't. Duke Med Health News; 2013 Jan; 19(1):3. PubMed ID: 23762971 [No Abstract] [Full Text] [Related]
9. Resolution of massive tophaceous gout with three urate-lowering drugs. Mejía-Chew C; Torres RJ; de Miguel E; Puig JG Am J Med; 2013 Nov; 126(11):e9-10. PubMed ID: 23978312 [No Abstract] [Full Text] [Related]
10. Long-term management of gout: nonpharmacologic and pharmacologic therapies. Chaichian Y; Chohan S; Becker MA Rheum Dis Clin North Am; 2014 May; 40(2):357-74. PubMed ID: 24703352 [TBL] [Abstract][Full Text] [Related]
11. Pegloticase and the patient with treatment-failure gout. Dave AJ; Kelly VM; Krishnan E Expert Rev Clin Pharmacol; 2012 Sep; 5(5):501-8. PubMed ID: 23121270 [TBL] [Abstract][Full Text] [Related]
13. Advances in pharmacotherapy for the treatment of gout. Robinson PC; Dalbeth N Expert Opin Pharmacother; 2015 Mar; 16(4):533-46. PubMed ID: 25547991 [TBL] [Abstract][Full Text] [Related]
14. Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials. Wortmann RL; Macdonald PA; Hunt B; Jackson RL Clin Ther; 2010 Dec; 32(14):2386-97. PubMed ID: 21353107 [TBL] [Abstract][Full Text] [Related]
15. Hyperuricemia and gout: new insights into pathogenesis and treatment. Pillinger MH; Rosenthal P; Abeles AM Bull NYU Hosp Jt Dis; 2007; 65(3):215-21. PubMed ID: 17922673 [TBL] [Abstract][Full Text] [Related]
16. Debulking the urate load to feel better. Richette P J Rheumatol; 2012 Jul; 39(7):1311-3. PubMed ID: 22753797 [No Abstract] [Full Text] [Related]
17. The Challenges of Approaching and Managing Gout. Fields TR Rheum Dis Clin North Am; 2019 Feb; 45(1):145-157. PubMed ID: 30447743 [TBL] [Abstract][Full Text] [Related]
18. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout. Biggers K; Scheinfeld N Curr Opin Investig Drugs; 2008 Apr; 9(4):422-9. PubMed ID: 18393109 [TBL] [Abstract][Full Text] [Related]
19. Pegloticase for treatment of tophaceous polyarticular gout. Seifried RM; Roberts J Hawaii J Med Public Health; 2013 Jul; 72(7):220-3. PubMed ID: 23901393 [TBL] [Abstract][Full Text] [Related]
20. Uricase and other novel agents for the management of patients with treatment-failure gout. Sundy JS; Hershfield MS Curr Rheumatol Rep; 2007 Jun; 9(3):258-64. PubMed ID: 17531181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]